Fujirebio & Agappe ink business collaboration for CLIA based immunoassay products

Japan-based Fujirebio Holdings and Indian firm Agappe Diagnostics have entered into an agreement of Contract Development...

January 22, 2024 | Monday | News
Taiwan's Bora Pharma acquires US-based Upsher-Smith for $210 M to fuel global expansion

Taiwan-based Bora Pharmaceuticals announced that its Board of Directors has approved the acquisition of Upsher-Smith L...

January 19, 2024 | Friday | News
China's WuXi Biologics announces research service agreement worth $20 M with BioNTech

China's WuXi Biologics has signed a research service agreement with Germany-based BioNTech SE, a next generation immunot...

January 11, 2024 | Thursday | News
“Pharma companies in South Korea will need to invest in skill development”

How is the contract manufacturing/development sector evolving in Korea? How is West leveraging opportunities in this spa...

January 5, 2024 | Friday | Opinion
AGC invests 50 Billion Yen to expand biopharmaceutical CDMO capability in Japan

AGC Inc, Japan-headquartered manufacturer of glass, chemicals, and high-tech materials, has decided to expand its biopha...

December 26, 2023 | Tuesday | News
Fujifilm invests $200 M into cell therapy development and manufacturing capabilities in US

Japan-headquartered Fujifilm Corporation has announced the investment of $200 million in two subsidiaries to significant...

December 8, 2023 | Friday | News
Aragen to invest $30 M for new bio-manufacturing site in India

Aragen, a leading Contract Research Development and Manufacturing Organization (CRDMO) for small molecules and biologics...

October 30, 2023 | Monday | News
Korean firm Samsung Biologics to further expand footprint into European market

Samsung Biologics, South Korea-based contract development and manufacturing organisation (CDMO), and Kurma Partners, a E...

October 24, 2023 | Tuesday | News
WuXi XDC and HKSTP promote development of bioconjugate drug industry in Hong Kong

WuXi XDC, a China-based Contract, Research, Development, Manufacturing Organisation (CRDMO) focused on the antibody drug...

October 19, 2023 | Thursday | News
Thermo Fisher expands manufacturing facility in US for complex biologic treatments

Thermo Fisher Scientific has expanded its manufacturing capacity in St. Louis, US to support biologic therapies for dise...

October 6, 2023 | Friday | News
Lotte Biologics to establish three new bio plants in Korea by 2030

Lotte Biologics has signed a land purchase agreement with the Incheon Free Economic Zone Authority (IFEZ) for the establ...

October 5, 2023 | Thursday | News
WuXi unveils first vaccines CDMO site in China

WuXi Vaccines, a leading contract development and manufacturing organisation (CDMO) focused on vaccine discovery, develo...

September 27, 2023 | Wednesday | News
Chinese startup Canton Biologics completes 300+ M Yuan series C financing

China-based startup Canton Biologics recently completed a Series C financing round exceeding 300 million yuan. This roun...

September 19, 2023 | Tuesday | News
Cytiva expands scientific, digital, and training offering in China

Recognising the long-term needs of the biopharma industry in China and Asia-Pacific, global life sciences leader Cytiva ...

September 18, 2023 | Monday | News
Korea's Samsung Biologics expands oncology agreement with Bristol Myers Squibb

South Korea-based Samsung Biologics has announced a new agreement with Bristol Myers Squibb (BMS) for large-scale manufa...

September 18, 2023 | Monday | News
Europe opens largest manufacturing facility for microbiome ecosystem therapies

MaaT Pharma, a clinical-stage biotech company and a leader in the development of Microbiome Ecosystem Therapies (ME...

September 12, 2023 | Tuesday | News
BIO Asia-Taiwan 2023: Embracing Asian Dynamics around precision health and CDMO

The Taiwan Bio Industry Organization (Taiwan BIO) and the global Biotechnology Innovation Organization (BIO) ignited Tai...

August 31, 2023 | Thursday | Analysis
China's T-Maximum Biotech selects GenScript CRISPR reagents to target high-grade gliomas

US-based GenScript Biotech, and China-based startup T-Maximum Biotech, a biotechnology company pioneering universal...

August 10, 2023 | Thursday | News